John Hancock Vitality is available with the company's life insurance policies — offering education, support, incentives, and rewards to encourage customers to take everyday steps toward a longer, healthier, better life. John Hancock and Prenuvo hope to explore additional ways to expand the collaboration in the future.

Learn more about John Hancock Vitality and Prenuvo.


1 The Prenuvo scan is currently available for customers 18 years of age and older. All U.S. locations, with the exception of the Prenuvo location in Boston, which is dedicated to the Hercules Research Study, are eligible for the John Hancock Vitality discount. Prenuvo currently has several clinics open across the U.S., with plans to open more clinics in the upcoming months. For a full list of clinics, check here.

2 Discounted access to Prenuvo's whole-body MRI scans will be offered to all eligible John Hancock Vitality Customers aged 18 and older who have completed the Vitality Health Review (VHR).

3 The Prenuvo whole body scan retails for $2,499 and is currently not covered by health insurance.

4 National Center for Chronic Disease Prevention and Health (NCCDPHP).

About John Hancock and Manulife

John Hancock is a unit of Manulife Financial Corporation, a leading international financial services provider that helps people make their decisions easier and lives better by providing financial advice, insurance, and wealth and asset management solutions. Manulife Financial Corporation trades as MFC on the TSX, NYSE, and PSE, and under 945 on the SEHK. Manulife can be found at manulife.com.

One of the largest life insurers in the United States, John Hancock supports more than ten million Americans with a broad range of financial products, including life insurance and annuities. John Hancock also supports US investors by bringing leading investment capabilities and retirement planning and administration expertise to individuals and institutions. Additional information about John Hancock may be found at johnhancock.com.

About Prenuvo

Prenuvo makes MRI scanning for early detection of cancer, "silent killers" like aneurysms, and other diseases more widely accessible. Combining cutting-edge quantification and analysis technology with radiation-free and non-invasive full-body scans, Prenuvo's patient-centric design is optimized to assess the body holistically and in under 60 minutes, compared with the 4-5 hours it would take to achieve this level of insight from conventional MRI scans.

Prenuvo is backed by leading venture capital firms and investors in health, fitness and category-defining consumer brands such as Felicis Ventures [investors in Fitbit (IPO), Guardant Health (IPO) and Ring (acq. by Amazon)], 23AndMe CEO Anne Wojcicki, Nest founder Tony Fadell, Eric Schmidt, Cindy Crawford, Lasker award recipient Dr. Timothy A. Springer and Casamigos co-founder Rande Gerber.

Back to HCB News

MRI Homepage